AlgiPharma AS

Patent Applications and Registrations

Patent applications and USPTO patent grants for AlgiPharma AS.The latest application filed is for "use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure".

Company Profile

6.15.16

AlgiPharma AS - Sandvika NO
Algipharma AS - Sandvika, Baerum N/A NO
Algipharma AS - Baerum NO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Use Of Alginate Oligomers In The Anticoagulation Therapy Of Subjects At Risk Of Blood Clots Which Have An Abnormally Dense Microstructure App 20220305050 - Williams; Rhodri ; et al.	2022-09-29
Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract Grant 11,413,306 - Dessen , et al. August 16, 2	2022-08-16
Method for the qualitative and quantitative detection of alginate oligomers in body fluids Grant 11,385,174 - Dessen , et al. July 12, 2	2022-07-12
Method For The Qualitative And Quantitative Detection Of Alginate Oligomers In Body Fluids App 20220074853 - Dessen; Arne ; et al.	2022-03-10
Inhalable Powder Formulations Of Alginate Oligomers App 20210386666 - NYAMBURA; Bildad ; et al.	2021-12-16
Use Of Alginate Oligomers To Enhance The Translocation Of Micro/nanoparticles Across Mucus Layers App 20210030891 - Tagalakis; Aristides ; et al.	2021-02-04
Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction Grant 10,751,363 - Dessen , et al. A	2020-08-25
Use of alginate oligomers in combating biofilms Grant 10,624,920 - Onsoyen , et al.	2020-04-21
A Companion Diagnostic Method For Use In The Treatment Of Cystic Fibrosis With Alginate Oligomers App 20190360925 - Lewis; Paul ; et al.	2019-11-28
Polymyxin-alginate Oligomer Conjugates App 20190328833 - Ferguson; Elaine ; et al.	2019-10-31
Alginate Oligomers For The Treatment Or Prevention Of Microbial Overgrowth In The Intestinal Tract App 20190117683 - Dessen; Arne ; et al.	2019-04-25
Inhalable Powder Formulations Of Alginate Oligomers App 20180235879 - NYAMBURA; Bildad ; et al.	2018-08-23
Use Of Alginate Oligomers In Combating Biofilms App 20180092939 - Onsoyen; Edvar ; et al.	2018-04-05
Use Of Alginate Oligomers And Cftr Modulators In The Treatment Of Conditions Associated With Cftr Dysfunction App 20180055873 - Dessen; Arne ; et al.	2018-03-01
Use of alginate oligomers in combating biofilms Grant 9,877,983 - Onsoyen , et al. January 30, 2	2018-01-30
Alginate oligomers for use in overcoming multidrug resistance in bacteria Grant 9,801,901 - Onsoyen , et al. October 31, 2	2017-10-31
Use Of Alginate Oligomers As Blood Anticoagulants App 20160331777 - DESSEN; Arne ; et al.	2016-11-17
Alginate Oligomers For Use In Overcoming Multidrug Resistance In Bacteria App 20150238520 - ONSOYEN; EDVAR ; et al.	2015-08-27
Alginate oligomers for use in overcoming multidrug resistance in bacteria Grant 9,018,158 - Onsoyen , et al. April 28, 2	2015-04-28
Treatment of Acinetobacter with alginate oligomers and antibiotics Grant 8,815,831 - Onsoyen , et al. August 26, 2	2014-08-26
Use Of Alginate Oligomers In Combating Biofilms App 20140205643 - ONSOYEN; EDVAR ; et al.	2014-07-24
Use of alginate oligomers in combating biofilms Grant 8,680,072 - Onsoyen , et al. March 25, 2	2014-03-25
Alginate Oligomers For Use In Overcoming Multidrug Resistance In Bacteria App 20120122768 - Onsoyen; Edvar ; et al.	2012-05-17
Treatment Of Acinetobacter With Alginate Oligomers And Antibiotics App 20120115803 - Onsoyen; Edvar ; et al.	2012-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.